Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PGH in HER2+ Breast Cancer
NCT00532857Phase 2Completed
- Sponsor
- Jungsil Ro
- Start
- Mar 2007
- Primary completion
- Feb 2008
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, gemcitabine, trastuzumab in breast cancer, sponsored by Jungsil Ro. Started Mar 2007; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00532857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532857.